Cited by 54Alzheimer's disease research and treatmentsDiet, Metabolism, and DiseaseAdipokines, Inflammation, and Metabolic Diseases

Metabolic disturbances of a high-fat diet are dependent on APOE genotype and sex.

Open access
Jones, Nahdia S., Watson, Katarina Q., Rebeck, G. William·2019·eneuro

Abstract

Apolipoprotein E4 (APOE4) is the strongest genetic risk factor for Alzheimer’s disease (AD).APOE4 is also associated with an increased risk of metabolic syndrome. Obesity is a major environmental risk factor for AD. While APOE genotype and obesity independently affect metabolism and cognition, they may also have synergistic effects. Here, we examined the metabolic and behavioral alterations associated with a high-fat diet (HFD) in male and female APOE knock-in mice. Male and female mice were fed a 45% kcal HFD or a 10% kcal low-fat diet (LFD) for 12 weeks and adipose tissue accumulation, glucose levels, anxiety-like behavior, and spatial memory were examined. We found that with HFD, male APOE4 mice were more susceptible to metabolic disturbances, including visceral adipose tissue (VAT) accumulation and glucose intolerance when compared to APOE3 mice, while female APOE3 and APOE4 mice had similar metabolic responses. Behaviorally, there were no effects of HFD in mice of either genotype. Our results suggest that metabolic responses to HFD are dependent on both sex and APOE genotype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/eneuro.0267-19.2019

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Addition of a high fat/high sugar diet exacerbates Alzheimer's disease phenotypes in mouse models relevant to early-onset AD.

    “Also, the addition of an HFD exacerbated AD phenotypes in mouse models relevant to early-onset AD (Knight et al., 2014; Jones et al., 2019; Bracko et al., 2020; Robison et al., 2020; Jones et al., 2021).”

    From Plcg2M28L Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer’s Disease-Relevant Phenotypes in Mice (2022) · cites this paper as Jones et al., 2019

    The Discussion (page unavailable) reports that high-fat diets worsened cognitive deficits or AD pathology in some AD mouse models, which supports the general point. But this paper studied APOE knock-in mice, not an early-onset AD model, and found no robust diet-related behavioral effects in its own experiment. The cited passages also do not establish a high-sugar diet. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • With HFD, male APOE4 mice were more susceptible to metabolic disturbances, including glucose intolerance, compared to APOE3 mice.

    “In one study, Jones et al. (2019) found that with HFD, male APOE4 mice were more susceptible to metabolic disturbances, including glucose intolerance when compared to APOE3 mice.”
  • Behavioral deficits were not observed due to HFD, suggesting that metabolic responses to HFD are dependent on both sex and APOE genotype.

    “Behavioral deficits were not observed due to HFD, suggesting that metabolic responses to HFD are dependent on both sex and APOE genotype.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 47

  1. Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N (2008) Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice. Int J Obes (Lond) 32: 1595– 1605. 10.1038/ijo.2008.143 18725890 PMC2805194 · DOI
  2. Arbones-Mainar JM, Johnson LA, Torres-Perez E, Garcia AE, Perez-Diaz S, Raber J, Maeda N (2016) Metabolic shifts toward fatty-acid usage and increased thermogenesis are associated with impaired adipogenesis in mice expressing human APOE4. Int J Obes (Lond) 40: 1574– 1581. 10.1038/ijo.2016.93 27163745 PMC5063049 · DOI
  3. Arnold SE, Lucki I, Brookshire BR, Carlson GC, Browne CA, Kazi H, Bang S, Choi BR, Chen Y, McMullen MF, Kim SF (2014) High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol Dis 67: 79– 87. 10.1016/j.nbd.2014.03.011 24686304 PMC4083060 · DOI
  4. Barron AM, Rosario ER, Elteriefi R, Pike CJ (2013) Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer's disease. PLoS One 8: e78554. 10.1371/journal.pone.0078554 24205258 PMC3810257 · DOI
  5. Besser LM, Gill DP, Monsell SE, Brenowitz W, Meranus DH, Kukull W, Gustafson DR (2014) Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord 28: 36– 43. 10.1097/WAD.0000000000000005 24126214 PMC3945175 · DOI
  6. Bloor ID, Symonds ME (2014) Sexual dimorphism in white and brown adipose tissue with obesity and inflammation. Horm Behav 66: 95– 103. 10.1016/j.yhbeh.2014.02.007 24589990 · DOI
  7. Bour A, Grootendorst J, Vogel E, Kelche C, Dodart JC, Bales K, Moreau PH, Sullivan PM, Mathis C (2008) Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks. Behav Brain Res 193: 174– 182. 10.1016/j.bbr.2008.05.008 18572260 · DOI · Paper page
  8. Christensen A, Pike CJ (2019) APOE genotype affects metabolic and Alzheimer-related outcomes induced by Western diet in female EFAD mice. FASEB J 33: 4054– 4066. 10.1096/fj.201801756R 30509127 PMC6404574 · DOI
  9. Elosua R, Demissie S, Cupples LA, Meigs JB, Wilson PW, Schaefer EJ, Corella D, Ordovas JM (2003) Obesity modulates the association among APOE genotype, insulin, and glucose in men. Obes Res 11: 1502– 1508. 10.1038/oby.2003.201 14694215 · DOI
  10. Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, Schmidt R (2005) Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 64: 1704– 1711. 10.1212/01.WNL.0000161871.83614.BB 15911795 · DOI
  11. Ghebranious N, Mukesh B, Giampietro PF, Glurich I, Mickel SF, Waring SC, McCarty CA (2011) A pilot study of gene/gene and gene/environment interactions in Alzheimer disease. Clin Med Res 9: 17– 25. 10.3121/cmr.2010.894 20682755 PMC3064752 · DOI
  12. Gunstad J, Paul RH, Cohen RA, Tate DF, Spitznagel MB, Gordon E (2007) Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry 48: 57– 61. 10.1016/j.comppsych.2006.05.001 17145283 · DOI · Paper page
  13. Gustafson DR, Backman K, Waern M, Ostling S, Guo X, Zandi P, Mielke MM, Bengtsson C, Skoog I (2009) Adiposity indicators and dementia over 32 years in Sweden. Neurology 73: 1559– 1566. 10.1212/WNL.0b013e3181c0d4b6 19901247 PMC2777073 · DOI
  14. Hadaegh F, Hasheminia M, Lotfaliany M, Mohebi R, Azizi F, Tohidi M (2013) Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors. PLoS One 8: e76304 10.1371/journal.pone.0076304 24086723 PMC3785433 · DOI
  15. Hales CM, Carroll MD, Fryar CD, Ogden CL (2017) Prevalence of obesity among adults and youth: United States, 2015-2016. NCHS Data Brief 288: 1– 8. 29155689
  16. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409– 2415. 10.1172/JCI117936 7738205 PMC295872 · DOI · Paper page
  17. Huang Y, Mahley RW (2014) Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol Dis 72: 3– 12. 10.1016/j.nbd.2014.08.025 25173806 PMC4253862 · DOI · Paper page
  18. Huang Y, Weisgraber KH, Mucke L, Mahley RW (2004) Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J Mol Neurosci 23: 189– 204. 10.1385/JMN:23:3:189 15181247 · DOI · Paper page
  19. Huebbe P, Dose J, Schloesser A, Campbell G, Glüer CC, Gupta Y, Ibrahim S, Minihane AM, Baines JF, Nebel A, Rimbach G (2015) Apolipoprotein E (APOE) genotype regulates body weight and fatty acid utilization-Studies in gene-targeted replacement mice. Mol Nutr Food Res 59: 334– 343. 10.1002/mnfr.201400636 25381750 · DOI
  20. Hwang LL, Wang CH, Li TL, Chang SD, Lin LC, Chen CP, Chen CT, Liang KC, Ho IK, Yang WS, Chiou LC (2010) Sex differences in high-fat diet-induced obesity, metabolic alterations and learning, and synaptic plasticity deficits in mice. Obesity (Silver Spring) 18: 463– 469. 10.1038/oby.2009.273 19730425 · DOI · Paper page
  21. Janssen CI, Jansen D, Mutsaers MP, Dederen PJ, Geenen B, Mulder MT, Kiliaan AJ (2016) The effect of a high-fat diet on brain plasticity, inflammation and cognition in female ApoE4-knockin and ApoE-knockout mice. PLoS One 11: e0155307 10.1371/journal.pone.0155307 27171180 PMC4865084 · DOI
  22. Johnson LA, Torres ER, Impey S, Stevens JF, Raber J (2017) Apolipoprotein E4 and insulin resistance interact to impair cognition and alter the epigenome and metabolome. Sci Rep 7: 43701 10.1038/srep43701 28272510 PMC5341123 · DOI · Paper page
  23. Johnson LA, Torres ER, Weber Boutros S, Patel E, Akinyeke T, Alkayed NJ, Raber J (2019) Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response. J Cereb Blood Flow Metab 39: 770– 781. 10.1177/0271678X17746186 29215310 PMC6498752 · DOI · Paper page
  24. Jones NS, Rebeck GW (2018) The synergistic effects of APOE genotype and obesity on Alzheimer's disease risk. Int J Mol Sci 20:E63. 10.3390/ijms20010063 30586872 PMC6337558 · DOI
  25. Kempuraj D, Thangavel R, Selvakumar GP, Zaheer S, Ahmed ME, Raikwar SP, Zahoor H, Saeed D, Natteru PA, Iyer S, Zaheer A (2017) Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration. Front Cell Neurosci 11: 216. 28790893 PMC5522882
  26. Kesby JP, Kim JJ, Scadeng M, Woods G, Kado DM, Olefsky JM, Jeste DV, Achim CL, Semenova S (2015) Spatial cognition in adult and aged mice exposed to high-fat diet. PLoS One 10: e0140034. 10.1371/journal.pone.0140034 26448649 PMC4598128 · DOI
  27. Kothari V, Luo Y, Tornabene T, O'Neill AM, Greene MW, Geetha T, Babu JR (2017) High fat diet induces brain insulin resistance and cognitive impairment in mice. Biochim Biophys Acta Mol Basis Dis 1863: 499– 508. 10.1016/j.bbadis.2016.10.006 27771511 · DOI
  28. Lin B, Hasegawa Y, Takane K, Koibuchi N, Cao C, Kim-Mitsuyama S (2016) High-fat-diet intake enhances cerebral amyloid angiopathy and cognitive impairment in a mouse model of Alzheimer's disease, independently of metabolic disorders. J Am Heart Assoc 5:e003154. 10.1161/JAHA.115.003154 27412896 PMC4937262 · DOI
  29. Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9: 106– 118. 10.1038/nrneurol.2012.263 23296339 PMC3726719 · DOI · Paper page
  30. Mathieu P, Poirier P, Pibarot P, Lemieux I, Després JP (2009) Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 53: 577– 584. 10.1161/HYPERTENSIONAHA.108.110320 19237685 · DOI
  31. Medrikova D, Jilkova ZM, Bardova K, Janovska P, Rossmeisl M, Kopecky J (2012) Sex differences during the course of diet-induced obesity in mice: adipose tissue expandability and glycemic control. Int J Obes (Lond) 36: 262– 272. 10.1038/ijo.2011.87 21540832 · DOI
  32. Moser VA, Pike CJ (2016) Obesity and sex interact in the regulation of Alzheimer's disease. Neurosci Biobehav Rev 67: 102– 118. 10.1016/j.neubiorev.2015.08.021 26708713 PMC4912955 · DOI
  33. Moser VA, Pike CJ (2017) Obesity accelerates Alzheimer-related pathology in APOE4 but not APOE3 mice. eNeuro 4: ENEURO.0077-17.2017. 10.1523/ENEURO.0077-17.2017 28612048 PMC5469027 · DOI
  34. Neth BJ, Craft S (2017) Insulin resistance and Alzheimer's disease: bioenergetic linkages. Front Aging Neurosci 9: 345. 29163128 PMC5671587
  35. Pradhan AD (2014) Sex differences in the metabolic syndrome: implications for cardiovascular health in women. Clin Chem 60: 44– 52. 10.1373/clinchem.2013.202549 24255079 · DOI
  36. Raber J, Huang Y, Ashford JW (2004) ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 25: 641– 650. 10.1016/j.neurobiolaging.2003.12.023 15172743 · DOI · Paper page
  37. Rodriguez GA, Burns MP, Weeber EJ, Rebeck GW (2013) Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex. Learn Mem 20: 256– 266. 10.1101/lm.030031.112 23592036 PMC3630489 · DOI
  38. Seibenhener ML, Wooten MC (2015) Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp. Advance online publication. Retrieved February 6, 2015. doi: 10.3791/52434. PMC4354627 25742564 · DOI
  39. Speidell AP, Demby T, Lee Y, Rodriguez O, Albanese C, Mandelblatt J, Rebeck GW (2019) Development of a human APOE knock-in mouse model for study of cognitive function after cancer chemotherapy. Neurotox Res 35: 291– 303. 10.1007/s12640-018-9954-7 30284204 PMC6333492 · DOI
  40. Tejedor MT, Garcia-Sobreviela MP, Ledesma M, Arbones-Mainar JM (2014) The apolipoprotein E polymorphism rs7412 associates with body fatness independently of plasma lipids in middle aged men. PLoS One 9: e108605 10.1371/journal.pone.0108605 25268647 PMC4182517 · DOI
  41. To AW, Ribe EM, Chuang TT, Schroeder JE, Lovestone S (2011) The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice. PLoS One 6: e16991 10.1371/journal.pone.0016991 21347323 PMC3037394 · DOI
  42. Tolppanen AM, Ngandu T, Kåreholt I, Laatikainen T, Rusanen M, Soininen H, Kivipelto M (2014) Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. J Alzheimers Dis 38: 201– 209. 10.3233/JAD-130698 23948937 · DOI
  43. Torres-Perez E, Ledesma M, Garcia-Sobreviela MP, Leon-Latre M, Arbones-Mainar JM (2016) Apolipoprotein E4 association with metabolic syndrome depends on body fatness. Atherosclerosis 245: 35– 42. 10.1016/j.atherosclerosis.2015.11.029 26691908 · DOI
  44. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K (2005) Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 330: 1360 10.1136/bmj.38446.466238.E0 15863436 PMC558283 · DOI · Paper page
  45. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71: 1057– 1064. 10.1212/01.wnl.0000306313.89165.ef 18367704 · DOI · Paper page
  46. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821– 1830. 10.1172/JCI200319451 14679177 PMC296998 · DOI · Paper page
  47. Zade D, Beiser A, McGlinchey R, Au R, Seshadri S, Palumbo C, Wolf PA, DeCarli C, Milberg W (2013) Apolipoprotein epsilon 4 allele modifies waist-to-hip ratio effects on cognition and brain structure. J Stroke Cerebrovasc Dis 22: 119– 125. 10.1016/j.jstrokecerebrovasdis.2011.06.020 21835633 PMC3613758 · DOI

Cited by

Sorted by citations

Authors
Jones, N. S., Watson, K. Q., & Rebeck, G. W.
Affiliations
Georgetown University (US)
Corresponding author
Rebeck, G. William
Venue
eneuro
Published
2019-09
Volume
6
Issue
5
Pages
ENEURO.0267-19.2019
ISSN
2373-2822 (ISSN-L)
OpenAlex
W2976687323
Cited by
54
References
8
Citations by year
2026: 4 · 2025: 6 · 2024: 9 · 2023: 6 · 2022: 8 · 2021: 12 · 2020: 5 · 2019: 2 · 2018: 2
FWCI
4.63
Type
journal article
Language
en
Open access
Locations
  • eNeuro (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
HHS | NIH | National Institute of Neurological Disorders and Stroke (R01 NS10070-03, R01 NS100704-S2)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
APOE ε4, APOE genotype, high-fat diet, Alzheimer's disease risk, metabolic syndrome, obesity, sex differences, visceral adipose tissue, impaired glucose tolerance, anxiety-like behavior, spatial memory
MeSH terms
Animals, Apolipoproteins E, Behavior, Animal, Female, Genotype, Insulin Resistance, Male, Mice, Inbred C57BL, Obesity, Sex Factors, Metabolic Syndrome, Intra-Abdominal Fat, Mice, Gene Knock-In Techniques, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review